These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20147424)

  • 1. Impact of clinician judgement on formulary committees' recommendations in Canada.
    Oremus M; Raina P; Eva K; Lavis J; Nair K; Lo A; Smith S
    J Health Serv Res Policy; 2010 Apr; 15(2):98-105. PubMed ID: 20147424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans.
    Ganther-Urmie JM; Nair KV; Valuck R; McCollum M; Lewis SJ; Turpin RS
    Am J Manag Care; 2004 Mar; 10(3):201-8. PubMed ID: 15032257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most?
    Glassman PA; Good CB; Kelley ME; Bradley M; Valentino M
    Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulary revision: eliciting the opinions of users.
    McGavock H; Wilson-Davis K; McGavock SA
    Br J Gen Pract; 1996 Jul; 46(408):419-21. PubMed ID: 8776914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence patient response to requests to change to a unified restrictive formulary.
    Smetana GW; Davis RB; Phillips RS
    J Gen Intern Med; 2004 Dec; 19(12):1212-9. PubMed ID: 15610332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence prescribing decisions.
    Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
    Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug formulary decision-making in two regional health authorities in British Columbia, Canada.
    Armstrong K; Mitton C; Carleton B; Shoveller J
    Health Policy; 2008 Dec; 88(2-3):308-16. PubMed ID: 18508151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk screening before starting stimulant medications and prescribing practices of canadian physicians: impact of the Health Canada advisory.
    Conway J; Wong KK; O'Connell C; Warren AE
    Pediatrics; 2008 Oct; 122(4):e828-34. PubMed ID: 18829780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of economic information in decision-making by the Advisory Committee on Immunization Practices.
    Dempsey AF; Cowan AE; Stokley S; Messonnier M; Clark SJ; Davis MM
    Vaccine; 2008 Oct; 26(42):5389-92. PubMed ID: 18708111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling prescription drug expenditures: a report of success.
    Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
    Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A proposed open formulary for a managed care program in Mexico. The Therapeutic and Pharmacological Committee of Mexico].
    Salud Publica Mex; 1999; 41(1):27-41. PubMed ID: 10081332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.
    Marshall DA; Willison DJ; Grootendorst P; LeLorier J; Maclure M; Kulin NA; Sheehy OE; Warren L; Sykora K; Rahme E
    Health Policy; 2007 Nov; 84(1):1-13. PubMed ID: 17570558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.
    Tannenbaum H; Davis P; Russell AS; Atkinson MH; Maksymowych W; Huang SH; Bell M; Hawker GA; Juby A; Vanner S; Sibley J
    CMAJ; 1996 Jul; 155(1):77-88. PubMed ID: 8673987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations.
    Broder KR; MacNeil A; Malone S; Schwartz B; Baughman AL; Murphy TV; Pickering LK; Moran JS
    Pediatrics; 2005 Jun; 115(6):1479-87. PubMed ID: 15930207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.